PROGRAMME
Kindly note that the programme will still be subject to changes.
Thursday, October 22, 2026
Room 1
08:00-09:00
AI in cardiovascular imaging: The time is now?! (All Levels)
Strengths and challenges of AI in imaging
AI in cardiac CT: Current role, future outlook
AI in cardiac MRI: Current role, future outlook
Q&A
09:00-09:05 Break
09:05-10:05
ESCR meets NASCI: Aorta imaging and beyond (All Levels)
ESCR aortic imaging practice recommendations
Non-invasive imaging in peripheral arterial occlusive disease
How does PCCT change vascular imaging?
Q&A
10:05-10:20 Industry Pitch Session
10:20-10:50 Break
10:50-11:00
Opening Ceremony
Introduction & Welcome to Rotterdam
11:00-12:00
Opening Session: Connect to Impact
ESCR: Connecting cardiovascular radiologists
Update on the EU Safe Hearts plan
The EU Safe Hearts plan: where does imaging fit in?
From diagnosis to prevention in Europe
12:00-12:10 Break
12:10-12:55 Industry Symposium
12:55-13:20 Break
13:20-14:35
Update on ischemia imaging (All Levels)
Guidelines on ischemia imaging in CAD management
Current role of FFR-CT and CT perfusion
Update on myocardial perfusion MRI
MRI to assess coronary vascular (dys)function
Q&A
14:35-14:40 Break
14:40-15:05 Industry Slot
15:05-15:35 Break
15:35-17:05
ESCR meets other imaging societies (All Levels)
Radiographers: role in cardiac imaging
Towards high-value, sustainable cardiac imaging
Updates on cardiac CT/MRI in European guidelines
MRI trials with impact on clinical routine
CT trials with clinical diagnostic impact
Role of PET/SPECT in cardiac diagnosis and management
Q&A
17:10-18:10
Interactive Session
Room 2
08:00-09:00
Scientific Session 1
09:00-09:05 Break
09:05-10:05
Scientific Session 2
10:05-13:20 Break
13:20-14:35
Imaging in cardio-oncology: Staying on top of treatment strategies (Advanced)
Imaging cardiac effects of non-immunotherapy systemic cancer therapies
Cardiac MRI in cancer immunotherapy: Are biopsies outdated?
Imaging of radiation‐induced coronary artery disease
Role of nuclear imaging in cardio-oncology
Q&A
14:35-15:35 Break
15:35-17:05
Basics of cardiac CT and MRI: Technical details explained (Basic)
MRI for tissue characterization
Contrast media injection protocols for EID-CT and PC-CT
Stress MRI perfusion – Pearls and pitfalls
Stress perfusion CT – Static and dynamic
4D flow MRI – When and how
Q&A
Friday, October 23, 2026
Room 1
CT at initial presentation in the ED: Can we exclude CAD?
MRI: Is it MINOCA/Takotsubo/myocarditis…?
Imaging in OHCA: How and why?
Q&A
Coronary calcium evaluation on chest CT?
ESTI/ESCR consensus on imaging pulmonary hypertension
Q&A
Risk stratification and follow-up in cardiomyopathies
Pediatric cardiomyopathies
Diving into hypertrophic phenotypes
Arrhythmogenic cardiomyopathy: A moving target
Q&A
Stent assessment: Current status
Cardiac fat measures: Ready for implementation?
How does PCCT change coronary CTA beyond stenosis?
Q&A
Free breathing MRI – Uncooperative patients/young children
Towards non-contrast cardiac MRI
Imaging in presence of pacemaker/ICD
Rapid, undersampled MRI
Q&A
Room 2
08:00-09:00
Scientific Session 3
09:00-09:05 Break
09:05-10:05
Scientific Session 4
10:05-10:35 Break
10:35-12:05
Imaging for cardiovascular intervention planning (All Levels)
Workup for mitral valve/LAA interventions
MRI guided interventions: Realtime imaging fusion
Workup for ablation of arrhythmias
Workup for TAVI
CCTA/CT-FFR to guide coronary intervention planning?
Q&A
12:05-14:15 Break
14:15-15:30
Connecting disciplines: The radiologist connected to… (All Levels)
The pulmonary oncologist (cardiac invading tumors)
The cardiogeneticist (genetic CMP)
The infectious disease specialist (inflammation/endocarditis)
The neurologist (cardioembolic stroke)
Q&A
15:30-16:30 Break
16:30-18:00
How to read congenital heart disease imaging: Case-based (Advanced)
Sequential segmental approach in congenital heart disease
Grown ups with (incidental) CHD
Tetralogy of Fallot
Shunts: ASD, VSD, PAPVR…
Transposition of the great arteries
Q&A
Saturday, October 24, 2026
Room 1
Updates in echocardiography for valvular imaging
Valvular imaging: 4D-flow MRI and beyond
Q&A
Spectral CT imaging: When is it helpful?
Standardization of CT reporting: How to – role for AI?
Q&A
Imaging of post-procedural complications: Case-based (All Levels)
Imaging after treatment of thoracic aorta
Imaging after cardiac transplantation/LVAD
Imaging after arrhythmia ablation
Post-valvular intervention imaging
Q&A
Role of MRI in heart failure guidelines
MRI tissue characteristics in ischemic cardiomyopathy
MRI tissue characteristics in non-ischemic cardiomyopathies
MRI: Role in myocarditis
Strain MRI: When, how, and why?
Q&A
15:25-15:30 Break
Closing Ceremony
Room 2
MRI: Signal artifacts
CT: Motion, trigger, stent and device artifacts
Q&A
Pearls in imaging for diagnosis of acute aortic syndrome
Triple rule out CT: When to consider?
Q&A
Vasculitis – small, medium and large vessels
The heart in auto-immune and connective tissue diseases
Update on MR/CT imaging of amyloidosis
The great mimicker: Sarcoidosis
Q&A